ERIN KRUSCHWITZ: Open Payments
NPI 1912156605 · CHARLOTTESVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$387 in 23 payments from 10 companies in 2025. Trend: 2023 $105 · 2024 $231 · 2025 $387
Food & beverage: $387
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $68 |
| Novo Nordisk Inc | 4 | $66 |
| AstraZeneca Pharmaceuticals LP | 4 | $61 |
| Amgen Inc. | 4 | $59 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $34 |
| Lilly USA, LLC | 2 | $32 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| Viatris Specialty LLC | 1 | $17 |
| Phadia US Inc. | 1 | $16 |
| Exact Sciences Corporation | 1 | $14 |
Products named: VRAYLAR, OTEZLA, Ozempic, BREZTRI, JARDIANCE, MOUNJARO, CAPVAXIVE, YUPELRI.
Industry payments across VA — which companies pay providers there.
